ArticleACS omega2026

Discovery of AKT1 Inhibitors for Obesity and Metabolic Dysfunction-Associated Steatotic Liver Disease Using QSAR-Guided Virtual Screening and Gaussian Accelerated Molecular Dynamics.

Kun Cao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.